These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 15519862)

  • 1. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy.
    Vajda FJ; O'brien TJ; Hitchcock A; Graham J; Cook M; Lander C; Eadie MJ
    J Clin Neurosci; 2004 Nov; 11(8):854-8. PubMed ID: 15519862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.
    Vajda FJ; O'Brien TJ; Hitchcock A; Graham J; Lander C
    J Clin Neurosci; 2003 Sep; 10(5):543-9. PubMed ID: 12948456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies.
    Vajda FJ; Hitchcock A; Graham J; O'Brien T; Lander C; Eadie M
    Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):468-74. PubMed ID: 17991111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
    Omtzigt JG; Los FJ; Grobbee DE; Pijpers L; Jahoda MG; Brandenburg H; Stewart PA; Gaillard HL; Sachs ES; Wladimiroff JW
    Neurology; 1992 Apr; 42(4 Suppl 5):119-25. PubMed ID: 1574165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenesis in repeated pregnancies in antiepileptic drug-treated women.
    Vajda FJ; O'Brien TJ; Lander CM; Graham J; Roten A; Eadie MJ
    Epilepsia; 2013 Jan; 54(1):181-6. PubMed ID: 22882134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications.
    Jazayeri D; Graham J; Hitchcock A; O'Brien TJ; Vajda FJE
    Seizure; 2018 Mar; 56():111-114. PubMed ID: 29471258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing Australian prescribing patterns for antiepileptic drugs in pregnancy and their possible consequences.
    Vajda FJ; Lander CM; Hitchcock A; Graham J; Solinas C; O'Brien T; Eadie MJ
    J Clin Neurosci; 2007 Jul; 14(7):611-7. PubMed ID: 17400456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry.
    Vajda FJ; Hitchcock A; Graham J; Solinas C; O'Brien TJ; Lander CM; Eadie MJ
    Eur J Neurol; 2006 Jun; 13(6):645-54. PubMed ID: 16796590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal valproate dosage and foetal malformations.
    Vajda FJ; Eadie MJ
    Acta Neurol Scand; 2005 Sep; 112(3):137-43. PubMed ID: 16097954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register.
    Vajda FJE; Graham JE; Hitchcock AA; Lander CM; O'Brien TJ; Eadie MJ
    Seizure; 2019 Feb; 65():6-11. PubMed ID: 30593875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate teratogenicity and epilepsy syndrome.
    Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
    Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy and teratogenicity of antiepileptic drugs.
    Eroğlu E; Gökçil Z; Bek S; Ulaş UH; Odabaşi Z
    Acta Neurol Belg; 2008 Jun; 108(2):53-7. PubMed ID: 18795597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
    Tomson T; Perucca E; Battino D
    Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
    Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
    Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prescribing of antiepileptic drugs for pregnant Australian women.
    Vajda FJ; Horgan D; Hollingworth S; Graham J; Hitchcock AA; Roten A; O'Brien TJ; Lander CM; Eadie MJ
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):49-53. PubMed ID: 21910695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register.
    Vajda FJ; Graham JE; Hitchcock AA; O'Brien TJ; Lander CM; Eadie MJ
    Seizure; 2010 Nov; 19(9):558-61. PubMed ID: 20739196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraception, pregnancy and lactation in women with epilepsy.
    Yerby MS
    Baillieres Clin Neurol; 1996 Dec; 5(4):887-908. PubMed ID: 9068887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.